Page 2 - Atlas Venture News Today : Breaking News, Live Updates & Top Stories | Vimarsana

INVENTIVA: Inventiva reports 2024 First Quarter Financial Information and provides a corporate update

INVENTIVA: Inventiva reports 2024 First Quarter Financial Information and provides a corporate update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBruxelles capitaleFrance generalPascaline clercCanaccord genuityAndre turenneAude lepreuxEuropean investment bankForum lyonBrunswick groupPatricial bankCorporate affairsInternational liver congressExchange commission onLong island city

Weight loss drugs in the spotlight as investors inject $400 million into new biotech startup

Weight loss drugs in the spotlight as investors inject $400 million into new biotech startup
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Aiolos bioEli lillyEli lilly zepboundJiangsu hengrui pharmaceuticalsBoehringer ingelheimShanghai stock exchange onBain capital life sciencesAtlas ventureJiangsu hengruiShanghai stock exchangeNovo nordiskBain capitalViking therapeuticsStructure therapeutics

Rx Rundown: Sanofi, Bayer, Sands Capital and more

Rx Rundown: Sanofi, Bayer, Sands Capital and more
mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.

United statesAscendis pharmaEli lillyReneo pharmaUniquity bioBrixton biosciencesEnveric biosciencesAcinonyx bioNabla bioCindome pharmaCardurion pharmaceuticalsBain capital life sciencesGilgamesh pharmaceuticalsBlood centers of americaCue healthBristol myers squibb

Investors put $400M into biotech licensing obesity drugs from China

BioPharma

Novo nordiskEli lillyAiolos bioEli lilly zepboundAtlas ventureJiangsu hengrui pharmaceuticalsShanghai stock exchangeBain capital life sciencesBoehringer ingelheimLyra capitalViking therapeuticsBain capitalCalled aiolos bio

ERS Genomics appoints John E Milad as Chief Executive Officer

ERS Genomics appoints John E Milad as Chief Executive Officer
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

United kingdomJohne miladNitec pharmaShaun foyEric rhodesUniversity of chicagoNational institute for healthHead of healthcare ventures at downingCare researchRoyal academy of engineeringGenomics limitedBoards of kidney research united kingdomAtlas ventureQuanta dialysis technologiesHealthcare venturesInvestment director